Statistics for Verrica Pharmaceuticals (id:6666 VRCA)

Valuation metrics

Market cap

38.01M

Enterprise value

62.16M

Trailing P/E (ttm)

-0.67

Forward P/E

-1.41

PEG ratio

-1.41

Price/Sales (ttm)

4.13

Price/Book (mrq)

-1.37

Enterprise Value/Revenue

6.75

Enterprise Value/EBITDA

-0.85

Overview

Shares outstanding

45.60M

Float

19.66M

Shares short

4.37M

% Held by insiders

0.32%

% Held by institutions

0.33%

Average volume (10 days)

1.19M

Average volume (90 days)

Price summary

52-Week low

0.70

52-Week high

11.41

52-Week change

-274.87%

Beta

1.46

50-Day moving average

1.45

200-Day moving average

5.10

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

85.44%

Operating margin

1.16K%

Operational effectiveness

Return on assets

-71.41%

Return on equity

-2,059.89%

Income statement

Revenue (ttm)

0.20

Revenue per share (ttm)

0.20

Quarterly revenue growth (yoy)

Gross profit (ttm)

4.38M

EBITDA

-73,387,000.00

Net income to common (ttm)

-84,991,000.00

Diluted EPS (ttm)

-1.84

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

22.96M

Total cash per share (mrq)

0.50

Total debt (mrq)

47.11M

Total Debt/Equity (mrq)

-1.38

Current ratio (mrq)

134.10%

Book value per share (mrq)

-0.75

Cash flow

Cash flow statement

-59,370,000.00

Levered free cash flow (LFCF)

-31,807,500.00